Concord, MA, United States of America

Reinier Beeuwkes

This inventor holds 13 USPTO granted patents and 3 published patent applications, plus 2 CIPO patents and 3 EPO patents. Top assignees: Ischemix, LLC, Therabite Corporation, Innoves, Inc.. Active years: 1994-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Reinier Beeuwkes. Retrieved from https://idiyas.com/inventor/reinier-beeuwkes

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 13 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 2.4

ph-index = 5

Forward Citations = 165(Granted Patents)


Company Filing History:


Years Active: 1994-2022

Loading Chart...
Loading Chart...
Loading Chart...
13 patents (USPTO):Explore Patents

Title: Inventor Reinier Beeuwkes

Introduction: Reinier Beeuwkes is a renowned inventor based in Concord, MA (US) known for his groundbreaking contributions to various fields.

Latest Patents: Beeuwkes holds several patents in the medical device industry, focusing on innovative solutions for improving patient outcomes and healthcare practices.

Career Highlights: With a background in engineering and a passion for problem-solving, Beeuwkes has successfully developed and patented numerous inventions that have revolutionized the way certain procedures are conducted in the medical field.

Collaborations: Throughout his career, Beeuwkes has collaborated with leading healthcare institutions and professionals to bring his inventions to life, ensuring that his innovations have a real-world impact.

Conclusion: Reinier Beeuwkes continues to be a driving force in the world of inventions, with his dedication to improving healthcare and patient well-being evident in his impressive body of work.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…